Last reviewed · How we verify
Boron-based Gel (Fibore) — Competitive Intelligence Brief
phase 3
Dermatology/Wound Care
Small molecule
Live · refreshed every 30 min
Target snapshot
Boron-based Gel (Fibore) (Boron-based Gel (Fibore)) — Tabriz University of Medical Sciences. Boron-based gel promotes wound healing and tissue repair through antimicrobial and anti-inflammatory properties.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Boron-based Gel (Fibore) TARGET | Boron-based Gel (Fibore) | Tabriz University of Medical Sciences | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Boron-based Gel (Fibore) CI watch — RSS
- Boron-based Gel (Fibore) CI watch — Atom
- Boron-based Gel (Fibore) CI watch — JSON
- Boron-based Gel (Fibore) alone — RSS
Cite this brief
Drug Landscape (2026). Boron-based Gel (Fibore) — Competitive Intelligence Brief. https://druglandscape.com/ci/boron-based-gel-fibore. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab